Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus

[1]  L. Szekely,et al.  PRIMA-1MET induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins , 2007, Oncogene.

[2]  Alberto Inga,et al.  The Biological Impact of the Human Master Regulator p53 Can Be Altered by Mutations That Change the Spectrum and Expression of Its Target Genes , 2006, Molecular and Cellular Biology.

[3]  I. Grummt,et al.  Cellular Stress and Nucleolar Function , 2005, Cell cycle.

[4]  A. Fersht,et al.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Dundr,et al.  The moving parts of the nucleolus , 2005, Histochemistry and Cell Biology.

[6]  C. Gespach,et al.  Nuclear bodies and compartments: functional roles and cellular signalling in health and disease. , 2004, Cellular signalling.

[7]  Matthias Mann,et al.  Bioinformatic analysis of the nucleolus. , 2003, The Biochemical journal.

[8]  A. Fersht,et al.  Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Lamond,et al.  Nuclear substructure and dynamics , 2003, Current Biology.

[10]  M. Chalfie,et al.  Nucleotide binding by the Mdm2 RING domain facilitates Arf-independent Mdm2 nucleolar localization. , 2003, Molecular cell.

[11]  U. Kutay,et al.  Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway , 2003, Journal of Cell Science.

[12]  R. McKay,et al.  A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. , 2002, Genes & development.

[13]  Galina Selivanova,et al.  Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database. , 2002, Carcinogenesis.

[14]  J. Swedlow,et al.  Macromolecular mobility inside the cell nucleus. , 2002, Trends in cell biology.

[15]  Xinbin Chen,et al.  The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis , 2002, Oncogene.

[16]  J. Węsierska‐Gądek,et al.  Escape of p53 protein from E6‐mediated degradation in HeLa cells after cisplatin therapy , 2002, International journal of cancer.

[17]  K. Collins,et al.  Subnuclear shuttling of human telomerase induced by transformation and DNA damage , 2002, Nature Cell Biology.

[18]  J. Borowiec,et al.  Stress-Dependent Nucleolin Mobilization Mediated by p53-Nucleolin Complex Formation , 2002, Molecular and Cellular Biology.

[19]  Pier Giuseppe Pelicci,et al.  Nucleophosmin regulates the stability and transcriptional activity of p53 , 2002, Nature Cell Biology.

[20]  U. Moll,et al.  Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Galina Selivanova,et al.  Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound , 2002, Nature Medicine.

[22]  C. Lorson,et al.  A Direct Interaction between the Survival Motor Neuron Protein and p53 and Its Relationship to Spinal Muscular Atrophy* , 2002, The Journal of Biological Chemistry.

[23]  C. Prives,et al.  Why Is p53 Acetylated? , 2001, Cell.

[24]  D. Lane,et al.  Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. , 2001, Experimental cell research.

[25]  H. O’Hagan,et al.  Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. , 2001, Journal of cell science.

[26]  M. Clarke,et al.  Regulation of p53 localization. , 2001, European journal of biochemistry.

[27]  E. Appella,et al.  Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.

[28]  G. Peters,et al.  Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus , 2001, Nature Cell Biology.

[29]  J. Węsierska‐Gądek,et al.  Segregation of nucleolar components coincides with caspase-3 activation in cisplatin-treated HeLa cells. , 2001, Journal of cell science.

[30]  L. Szekely,et al.  Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5. , 2001, The Journal of general virology.

[31]  Maria Carmo-Fonseca,et al.  To be or not to be in the nucleolus , 2000, Nature Cell Biology.

[32]  K. Vousden,et al.  Stress Signals Utilize Multiple Pathways To Stabilize p53 , 2000, Molecular and Cellular Biology.

[33]  M. Dundr,et al.  The nucleolus: an old factory with unexpected capabilities. , 2000, Trends in cell biology.

[34]  J. Milner,et al.  Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus , 2000, Oncogene.

[35]  B. Wullich,et al.  Two different forms of p53 localized differently within cells of urogenital tumours. , 1999, Cancer letters.

[36]  A. Levine,et al.  P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Charles J. Sherr,et al.  Nucleolar Arf sequesters Mdm2 and activates p53 , 1999, Nature Cell Biology.

[38]  A. Budde,et al.  p53 represses ribosomal gene transcription , 1999, Oncogene.

[39]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[40]  A. Zolotukhin,et al.  Nucleoporins Nup98 and Nup214 Participate in Nuclear Export of Human Immunodeficiency Virus Type 1 Rev , 1999, Journal of Virology.

[41]  M. Tyers,et al.  The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation. , 1998, Molecular cell.

[42]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[43]  L. Guarente,et al.  Nucleolar localization of the Werner syndrome protein in human cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[45]  X. Chen,et al.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. , 1996, Genes & development.

[46]  P. Bouvet,et al.  Nucleolin is a sequence-specific RNA-binding protein: characterization of targets on pre-ribosomal RNA. , 1996, Journal of molecular biology.

[47]  L. Bracco,et al.  Modulation of DNA topoisomerase I activity by p53. , 1996, Biochemistry.

[48]  D C Ward,et al.  Inhibition of RNA polymerase II transcription causes chromatin decondensation, loss of nucleolar structure, and dispersion of chromosomal domains. , 1996, Experimental cell research.

[49]  Y. Qi,et al.  Quantitation of the nucleophosmin/B23-translocation using imaging analysis. , 1996, Cancer letters.

[50]  M. Dundr,et al.  The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein. , 1995, Journal of cell science.

[51]  C. Prives,et al.  Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus , 1995, Cell.

[52]  A. Levine,et al.  The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes , 1994, Molecular and cellular biology.

[53]  M. Gossen,et al.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. , 1994, Molecular and cellular biology.

[54]  P. Pour,et al.  Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines. , 1993, Carcinogenesis.

[55]  J. Milner,et al.  Correlation between the conformational phenotype of p53 and its subcellular location. , 1992, Oncogene.

[56]  K. Kinzler,et al.  Identification of p53 as a sequence-specific DNA-binding protein , 1991, Science.

[57]  Y. Chentsov,et al.  Ultrastructural changes in nucleoli and fibrillar centers under the effect of local ultraviolet microbeam irradiation of interphase culture cells. , 1989, Experimental cell research.

[58]  L. Latonen,et al.  p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction. , 2003, Cellular signalling.

[59]  Angus I Lamond,et al.  The dynamics of the nucleolus. , 2003, Critical reviews in eukaryotic gene expression.

[60]  A. Amon,et al.  The nucleolus: the magician's hat for cell cycle tricks. , 2000, Current opinion in cell biology.

[61]  A. Amon,et al.  Erratum: The nucleolus: The magician's hat for cell cycle tricks (Current Opinion in Cell Biology (2000) 12 (372-377)) , 2000 .

[62]  M. Štros,et al.  Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box B-domain of HMG1 protein to supercoiled DNA. , 1998, European journal of biochemistry.

[63]  C. Prives,et al.  Functional dissection of p53 tumor suppressor protein. , 1997, Methods in enzymology.